Literature DB >> 23430657

Minimal "Self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles.

Pia L Rodriguez1, Takamasa Harada, David A Christian, Diego A Pantano, Richard K Tsai, Dennis E Discher.   

Abstract

Foreign particles and cells are cleared from the body by phagocytes that must also recognize and avoid clearance of "self" cells. The membrane protein CD47 is reportedly a "marker of self" in mice that impedes phagocytosis of self by signaling through the phagocyte receptor CD172a. Minimal "Self" peptides were computationally designed from human CD47 and then synthesized and attached to virus-size particles for intravenous injection into mice that express a CD172a variant compatible with hCD47. Self peptides delay macrophage-mediated clearance of nanoparticles, which promotes persistent circulation that enhances dye and drug delivery to tumors. Self-peptide affinity for CD172a is near the optimum measured for human CD172a variants, and Self peptide also potently inhibits nanoparticle uptake mediated by the contractile cytoskeleton. The reductionist approach reveals the importance of human Self peptides and their utility in enhancing drug delivery and imaging.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23430657      PMCID: PMC3966479          DOI: 10.1126/science.1229568

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  31 in total

1.  Role of CD47 as a marker of self on red blood cells.

Authors:  P A Oldenborg; A Zheleznyak; Y F Fang; C F Lagenaur; H D Gresham; F P Lindberg
Journal:  Science       Date:  2000-06-16       Impact factor: 47.728

2.  Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?

Authors:  R L Hong; C J Huang; Y L Tseng; V F Pang; S T Chen; J J Liu; F H Chang
Journal:  Clin Cancer Res       Date:  1999-11       Impact factor: 12.531

3.  The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.

Authors:  Stephen B Willingham; Jens-Peter Volkmer; Andrew J Gentles; Debashis Sahoo; Piero Dalerba; Siddhartha S Mitra; Jian Wang; Humberto Contreras-Trujillo; Robin Martin; Justin D Cohen; Patricia Lovelace; Ferenc A Scheeren; Mark P Chao; Kipp Weiskopf; Chad Tang; Anne Kathrin Volkmer; Tejaswitha J Naik; Theresa A Storm; Adriane R Mosley; Badreddin Edris; Seraina M Schmid; Chris K Sun; Mei-Sze Chua; Oihana Murillo; Pradeep Rajendran; Adriel C Cha; Robert K Chin; Dongkyoon Kim; Maddalena Adorno; Tal Raveh; Diane Tseng; Siddhartha Jaiswal; Per Øyvind Enger; Gary K Steinberg; Gordon Li; Samuel K So; Ravindra Majeti; Griffith R Harsh; Matt van de Rijn; Nelson N H Teng; John B Sunwoo; Ash A Alizadeh; Michael F Clarke; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

4.  Phylogenetic divergence of CD47 interactions with human signal regulatory protein alpha reveals locus of species specificity. Implications for the binding site.

Authors:  Shyamsundar Subramanian; Eric T Boder; Dennis E Discher
Journal:  J Biol Chem       Date:  2006-11-10       Impact factor: 5.157

5.  Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging.

Authors:  Derek W Bartlett; Helen Su; Isabel J Hildebrandt; Wolfgang A Weber; Mark E Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-17       Impact factor: 11.205

6.  Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells.

Authors:  Katsuto Takenaka; Tatiana K Prasolava; Jean C Y Wang; Steven M Mortin-Toth; Sam Khalouei; Olga I Gan; John E Dick; Jayne S Danska
Journal:  Nat Immunol       Date:  2007-11-04       Impact factor: 25.606

7.  In vivo imaging of 64Cu-labeled polymer nanoparticles targeted to the lung endothelium.

Authors:  Raffaella Rossin; Silvia Muro; Michael J Welch; Vladimir R Muzykantov; Daniel P Schuster
Journal:  J Nucl Med       Date:  2007-12-12       Impact factor: 10.057

8.  Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients.

Authors:  Jonathan K Armstrong; Georg Hempel; Susanne Koling; Linda S Chan; Timothy Fisher; Herbert J Meiselman; George Garratty
Journal:  Cancer       Date:  2007-07-01       Impact factor: 6.860

9.  IgG opsonization of HIV impedes provirus formation in and infection of dendritic cells and subsequent long-term transfer to T cells.

Authors:  Doris Wilflingseder; Zoltan Banki; Eduardo Garcia; Monika Pruenster; Gerald Pfister; Brigitte Muellauer; Damjan S Nikolic; Christoph Gassner; Christoph G Ammann; Manfred P Dierich; Vincent Piguet; Heribert Stoiber
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

10.  Inhibition of "self" engulfment through deactivation of myosin-II at the phagocytic synapse between human cells.

Authors:  Richard K Tsai; Dennis E Discher
Journal:  J Cell Biol       Date:  2008-03-10       Impact factor: 10.539

View more
  249 in total

1.  Engineered Materials for Cancer Immunotherapy.

Authors:  Alexander S Cheung; David J Mooney
Journal:  Nano Today       Date:  2015-08-01       Impact factor: 20.722

Review 2.  Progress in material design for biomedical applications.

Authors:  Mark W Tibbitt; Christopher B Rodell; Jason A Burdick; Kristi S Anseth
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-24       Impact factor: 11.205

Review 3.  Nanoparticles as a promising method to enhance the abscopal effect in the era of new targeted therapies.

Authors:  Ignacio Morales-Orue; Rodolfo Chicas-Sett; Pedro C Lara
Journal:  Rep Pract Oncol Radiother       Date:  2018-11-22

4.  Activatable Protein Nanoparticles for Targeted Delivery of Therapeutic Peptides.

Authors:  Xi Yu; Xingchun Gou; Peng Wu; Liang Han; Daofeng Tian; Fengyi Du; Zeming Chen; Fuyao Liu; Gang Deng; Ann T Chen; Chao Ma; Jun Liu; Sara M Hashmi; Xing Guo; Xiaolong Wang; Haitian Zhao; Xinran Liu; Xudong Zhu; Kevin Sheth; Qianxue Chen; Louzhen Fan; Jiangbing Zhou
Journal:  Adv Mater       Date:  2018-01-08       Impact factor: 30.849

5.  "Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis.

Authors:  Chia Chi M Ho; Nan Guo; Jonathan T Sockolosky; Aaron M Ring; Kipp Weiskopf; Engin Özkan; Yasuo Mori; Irving L Weissman; K Christopher Garcia
Journal:  J Biol Chem       Date:  2015-04-02       Impact factor: 5.157

Review 6.  Virus-Based Nanoparticles as Versatile Nanomachines.

Authors:  Kristopher J Koudelka; Andrzej S Pitek; Marianne Manchester; Nicole F Steinmetz
Journal:  Annu Rev Virol       Date:  2015-09-25       Impact factor: 10.431

7.  Therapeutic inflammatory monocyte modulation using immune-modifying microparticles.

Authors:  Daniel R Getts; Rachael L Terry; Meghann Teague Getts; Celine Deffrasnes; Marcus Müller; Caryn van Vreden; Thomas M Ashhurst; Belal Chami; Derrick McCarthy; Huiling Wu; Jin Ma; Aaron Martin; Lonnie D Shae; Paul Witting; Geoffrey S Kansas; Joachim Kühn; Wali Hafezi; Iain L Campbell; David Reilly; Jana Say; Louise Brown; Melanie Y White; Stuart J Cordwell; Steven J Chadban; Edward B Thorp; Shisan Bao; Stephen D Miller; Nicholas J C King
Journal:  Sci Transl Med       Date:  2014-01-15       Impact factor: 17.956

8.  Inhibition of SIRPα in dendritic cells potentiates potent antitumor immunity.

Authors:  Qiong Liu; Wen Wen; Liang Tang; Chen-Jie Qin; Yan Lin; Hui-Lu Zhang; Han Wu; Charles Ashton; Hong-Ping Wu; Jin Ding; Wei Dong; Le-Xing Yu; Wen Yang; Dan-Dan Huang; Meng-Chao Wu; Hong-Yang Wang; He-Xin Yan
Journal:  Oncoimmunology       Date:  2016-08-23       Impact factor: 8.110

Review 9.  Designer lipids for drug delivery: from heads to tails.

Authors:  Aditya G Kohli; Paul H Kierstead; Vincent J Venditto; Colin L Walsh; Francis C Szoka
Journal:  J Control Release       Date:  2014-05-06       Impact factor: 9.776

10.  The effect of hyperbranched polyglycerol coatings on drug delivery using degradable polymer nanoparticles.

Authors:  Yang Deng; Jennifer K Saucier-Sawyer; Christopher J Hoimes; Junwei Zhang; Young-Eun Seo; Jillian W Andrejecsk; W Mark Saltzman
Journal:  Biomaterials       Date:  2014-05-09       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.